Researchers developed an approach to treating prostate cancer, successfully eliminating cancerous cells in 73% of patients in ...
Men with prostate cancer diagnosed at an early stage may be able to slow the progression of their disease by adopting a ...
Medpage Today on MSN2d
Radioligand Shows Promise in Metastatic Hormone-Sensitive Prostate CancerIn metastatic hormone-sensitive prostate cancer (mHSPC), adding the radioligand 177 Lu-PSMA-617 (Pluvicto) to androgen ...
Black men with advanced prostate cancer have a greater chance of survival after immunotherapy treatment, at least in part, because of ancestral gene variants in immune responses.
Stereotactic body radiotherapy was associated with significantly better urinary continence and fewer sexual issues at 2 years ...
Permanent Secretary in the Ministry of Health, Dr. Laura Esprit has said that breast cancer continues to be a major concern ...
Under the new grant, Agarwal’s lab will work to not only confirm they have identified the correct compounds but to translate ...
Local radiation therapy appears beneficial for men with bone metastatic hormone-sensitive prostate cancer (mHSPC).
As part of the CURE® Educated Patient® Prostate Cancer Summit, an expert discussed the role genetic testing plays in ...
A ground-breaking study, conducted by researchers from the University of Virginia, Mount Sinai, the University of Michigan, ...
Prostate cancer starts when cells in the prostate gland grow out of control. Those cells can spread to other parts of the body and affect healthy tissue. This can happen for several reasons.
Exclusive: ‘Unfortunately, most of the genetic research that had been published focused only on people of white European ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback